SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-295398
Filing Date
2021-10-08
Accepted
2021-10-08 15:26:01
Documents
14
Period of Report
2021-10-08
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d224633d8k.htm   iXBRL 8-K 24719
2 EX-99.1 d224633dex991.htm EX-99.1 22945
6 GRAPHIC g224633dsp1.jpg GRAPHIC 2696
  Complete submission text file 0001193125-21-295398.txt   187516

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA rptx-20211008.xsd EX-101.SCH 2517
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE rptx-20211008_lab.xml EX-101.LAB 19419
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rptx-20211008_pre.xml EX-101.PRE 12118
7 EXTRACTED XBRL INSTANCE DOCUMENT d224633d8k_htm.xml XML 3742
Mailing Address 7210 FREDERICK-BANTING, SUITE 100 ST-LAURENT A8 H4S 2A1
Business Address 7210 FREDERICK-BANTING, SUITE 100 ST-LAURENT A8 H4S 2A1 (857) 412-7018
Repare Therapeutics Inc. (Filer) CIK: 0001808158 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39335 | Film No.: 211315201
SIC: 2834 Pharmaceutical Preparations